Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends approval of Sprimeo HCT for hypertension

Feb. 22, 2011

Prima BioMed receives scientific advice from EMA on CVac trial

Feb. 22, 2011

CHMP issues positive opinion on Novartis' Rasilamlo for high blood pressure

Feb. 21, 2011

EMA's CHMP recommends approval of Hizentra

Feb. 21, 2011

Merck Serono Europe withdraws MAA for Movectro

Feb. 21, 2011

European orphan drug status recommended for QLT-091001 in LCA and RP

Feb. 11, 2011

Johnson & Johnson reports highlights fourth quarter 2010

Feb. 9, 2011

EMA grants orphan drug status to GT-038 in retinitis pigmentosa

Feb. 9, 2011

FluEnz approved in E.U. for prevention of seasonal flu in children

Feb. 7, 2011

EMA approves sublingual sildenafil formulation X-Excite for erectile dysfunction

Feb. 3, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...